Abstract
Asthma is characterized by allergen-induced airway inflammation orchestrated by Th2 cells. Dendritic cells (DCs) were found to efficiently prime naive T-helper cells. Thus, modification of DC function may be used as an ideal tool to treat allergic asthma by changing CD4+ T-cell differentiation or suppressing Th2 development. In this study, we examined whether a DC-based vaccine can be applied to DCs modified with interleukin (IL)-10- and IL-12-expressing adenoviruses to prevent ovalbumin (OVA)-induced asthma in mice. Herein, we show that these modified DCs efficiently moderated the characteristics of asthma, including expressions of OVA-specific antibodies, airway hyperresponsiveness, eosinophilic airway inflammation, and Th2 cytokines production. Additionally, IL-10 and IL-12 gene-modified DCs enhanced the development of both T-helper type 1 (Th1) and IL-10+IFN-γ+ (interferon-γ) double-positive T cells in vivo. In vitro-generated OVA-specific IL-10+IFN-γ+CD4+ T cells inhibited the proliferation of naive CD4+ T cells, and this suppressive effect was a cell contact-dependent mechanism. Furthermore, we showed that combined cytokine-modulated DCs could alleviate established allergic airway inflammation. Taken together, these results suggest that IL-10 and IL-12 gene-modulated DCs are effective in suppressing asthmatic airway inflammation through both immune deviation and immune suppression and are a potential therapeutic approach for asthma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout








Similar content being viewed by others
References
Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Knowles G et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990; 142: 1407–1413.
Factor P . Gene therapy for asthma. Mol Ther 2003; 7: 148–152.
Hansen G, Berry G, DeKruyff RH, Umetsu DT . Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999; 103: 175–183.
Randolph DA, Carruthers CJ, Szabo SJ, Murphy KM, Chaplin DD . Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. J Immunol 1999; 162: 2375–2383.
Moser M, Murphy KM . Dendritic cell regulation of TH1-TH2 development. Nat Immunol 2000; 1: 199–205.
Akbari O, Umetsu DT . Role of regulatory dendritic cells in allergy and asthma. Curr Allergy Asthma Rep 2005; 5: 56–61.
Abbas AK, Murphy KM, Sher A . Functional diversity of helper T lymphocytes. Nature 1996; 383: 787–793.
Borish L . IL-10: evolving concepts. J Allergy Clin Immunol 1998; 101: 293–297.
de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE . Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209–1220.
Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A . IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815–3822.
Kasama T, Strieter RM, Lukacs NW, Burdick MD, Kunkel SL . Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 1994; 152: 3559–3569.
Takanaski S, Nonaka R, Xing Z, O’Byrne P, Dolovich J, Jordana M . Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 1994; 180: 711–715.
Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M . Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151–1164.
Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997; 389: 737–742.
Vieira PL, Christensen JR, Minaee S, O’Neill EJ, Barrat FJ, Boonstra A et al. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells. J Immunol 2004; 172: 5986–5993.
Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF et al. In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195: 603–616.
Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993; 177: 1199–1204.
Wolf SF, Sieburth D, Sypek J . Interleukin 12: a key modulator of immune function. Stem Cells 1994; 12: 154–168.
Gerosa F, Paganin C, Peritt D, Paiola F, Scupoli MT, Aste-Amezaga M et al. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-γ and interleukin-10. J Exp Med 1996; 183: 2559–2569.
Chang HD, Radbruch A . The pro- and anti-inflammatory potential of interleukin-12. Ann NY Acad Sci 2007; 1109: 40–46.
Trinchieri G . Regulatory role of T cells producing both interferon-γ and interleukin 10 in persistent infection. J Exp Med 2001; 194: F53–F57.
Cosmi L, Santarlasci V, Angeli R, Liotta F, Maggi L, Frosali F et al. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-γ- and interleukin-10-production. Clin Exp Allergy 2006; 36: 261–272.
Stock P, Akbari O, Berry G, Freeman GJ, Dekruyff RH, Umetsu DT . Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol 2004; 5: 1149–1156.
Ye YL, Lee YL, Chuang ZJ, Lai HJ, Chen CC, Tao MH et al. Dendritic cells modulated by cytokine-expressing adenoviruses alleviate eosinophilia and airway hyperresponsiveness in an animal model of asthma. J Allergy Clin Immunol 2004; 114: 88–96.
Kuipers H, Heirman C, Hijdra D, Muskens F, Willart M, van Meirvenne S et al. Dendritic cells retrovirally overexpressing IL-12 induce strong Th1 responses to inhaled antigen in the lung but fail to revert established Th2 sensitization. J Leukoc Biol 2004; 76: 1028–1038.
Akbari O, DeKruyff RH, Umetsu DT . Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001; 2: 725–731.
Zuany-Amorim C, Hailé S, Leduc D, Dumarey C, Huerre M, Vargaftig BB et al. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest 1995; 95: 2644–2651.
Lee Y, Fu C, Chiang B . Administration of interleukin-12 exerts a therapeutic instead of a long-term preventive effect on mite Der p I allergen-induced animal model of airway inflammation. Immunology 1999; 97: 232–240.
Hsu CY, Liu HE, Sheu FY, Leu SJ, Chiang BL, Hsiao G et al. Synergistic therapeutic effects of combined adenovirus-mediated interleukin-10 and interleukin-12 gene therapy on airway inflammation in asthmatic mice. J Gene Med 2010; 12: 11–21.
Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH . Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192: 1213–1222.
Akbari O, Freeman GJ, Meyer EH, Greenfield EA, Chang TT, Sharpe AH et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002; 8: 1024–1032.
Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E . Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003; 361: 1869–1871.
Batten M, Kljavin NM, Li J, Walter MJ, de Sauvage FJ, Ghilardi N . Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J Immunol 2008; 180: 2752–2756.
Jankovic D, Kullberg MC, Feng CG, Goldszmid RS, Collazo CM, Wilson M et al. Conventional T-bet+Foxp3− Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 2007; 204: 273–283.
Anderson CF, Oukka M, Kuchroo VJ, Sacks D . CD4+CD25−Foxp3− Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 2007; 204: 285–297.
Jankovic D, Kullberg MC, Hieny S, Caspar P, Collazo CM, Sher A . In the absence of IL-12, CD4+ T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10−/− setting. Immunity 2002; 16: 429–439.
Svetic A, Jian YC, Lu P, Finkelman FD, Gause WC . Brucella abortus induces a novel cytokine gene expression pattern characterized by elevated IL-10 and IFN-γ in CD4+ T cells. Int Immunol 1993; 5: 877–883.
Gerosa F, Nisii C, Righetti S, Micciolo R, Marchesini M, Cazzadori A et al. CD4+ T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin Immunol 1999; 92: 224–234.
Lee YL, Ye YL, Yu CI, Wu YL, Lai YL, Ku PH et al. Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthma. Hum Gene Ther 2001; 12: 2065–2079.
Fu CL, Chuang YH, Huang HY, Chiang BL . Induction of IL-10 producing CD4+ T cells with regulatory activities by stimulation with IL-10 gene-modified bone marrow derived dendritic cells. Clin Exp Immunol 2008; 153: 258–268.
Lee CC, Huang HY, Chiang BL . Lentiviral-mediated GATA-3 RNAi decreases allergic airway inflammation and hyperresponsiveness. Mol Ther 2008; 16: 60–65.
Acknowledgements
This study was supported by grants from Cathay General Hospital (95 CGH-TMU-06) and from the National Science Council of the Republic of China (NSC95-2314-B-038-052).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on Gene Therapy website
Rights and permissions
About this article
Cite this article
Hsu, CY., Leu, SJ., Chiang, BL. et al. Cytokine gene-modulated dendritic cells protect against allergic airway inflammation by inducing IL-10+IFN-γ+CD4+ T cells. Gene Ther 17, 1011–1021 (2010). https://doi.org/10.1038/gt.2010.39
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/gt.2010.39
Keywords
This article is cited by
-
Variation of Regulatory T Lymphocytes in the Peripheral Blood of Children with Allergic Rhinitis
Archivum Immunologiae et Therapiae Experimentalis (2018)
-
Breast regression protein-39 (BRP-39) promotes dendritic cell maturation in vitro and enhances Th2 inflammation in murine model of asthma
Acta Pharmacologica Sinica (2012)